A low prevalence of purified protein derivative test positivity in Turkish patients with rheumatoid arthritis. Association with clinical features and HRCT findings

Clinical and Experimental Rheumatology

Volumn 25, Issue 1, 2007, Pages 54-59

  Köker, Ibrahim Hakki ^a   Karlikaya, Celal ^a   Tunçbilek, Nermin ^a   Pamuk, Ömer Nuri ^a   Çakir, Necati ^a,b  

^a TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^b NONE   (Turkey)

Author keywords

Chest x ray; High resolution computerized tomography; Purified protein derivative (PPD) test; Rheumatoid arthritis; Tuberculosis

Indexed keywords

ANTIMALARIAL AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; LEFLUNOMIDE; METHOTREXATE; RHEUMATOID FACTOR; SALAZOSULFAPYRIDINE; STEROID;

ADULT; AGED; ANKYLOSING SPONDYLITIS; ARTICLE; BONE EROSION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; GOUT; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; OSTEOARTHRITIS; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SEROPREVALENCE; SMOKING; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; TURKEY (REPUBLIC); VASCULITIS; COMPUTER ASSISTED TOMOGRAPHY; IMMUNOLOGY; LUNG TUBERCULOSIS; MIDDLE AGED; RADIOGRAPHY; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; MALE; MIDDLE AGED; RADIOGRAPHY, THORACIC; RESPIRATORY FUNCTION TESTS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; TURKEY;

EID: 33947600174     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. TANOUE LT: Pulmonary manifestations of rheumatoid arthritis. Clin Chest Med 1998; 19: 667-85.
2. ANAYA JM, DIETHELM L, ORTIZ LA et al.: Pulmonary involvement in rheumatoid arthritis. Semin Arthritis Rheum 1995; 24: 242-54.
3. HAMILTON CD: Tuberculosis in the cytokine era: what rheumatologists need to know. Arthritis Rheum 2003; 48: 2085-91.
4. IMPERATO AK, SMILES S, ABRAMSON SB: Long-term risks associated with biologic response modifiers used in rheumatic dis eases. Curr Opin Rheumatol 2004; 16: 199-205.
5. American Thoracic Society: Targeted tuberculin testing and treatment of latent tuberculosis infection. Am Resp Crit Care Med 2000; 161: 221-47.
6. PANAYI G, CORRIGALL V, PITZALIS C: Pathogenesis of rheumatoid arthritis. The role of T cells and other beasts. Rheum Dis Clin North Am 2001; 27: 1-18.
7. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
8. PREVOO ML, van't HOF M, KUPER HH, van LEEWUEN M, van de PUTTE L, van RIEL P: Modified disease activity scores that include twenty-eight-joint counts: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995; 38: 44-8.
9. IKEZOE J, TAKEUCHI N, JOHKOH T et al.: CT appearance of pulmonary tuberculosis in diabetic and immunocompromised patients. Comparison with patients who had no underlying disease. AJR Am J Roentgenol 1992; 159: 1175-9.
10. TAN EM, COHEN AS, FRIES JF et al.: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
11. van der LINDEN S, VALKENBURG HA, CATS A: Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-8.
12. WALLACE SL, ROBINSON H, MASI AT, DECKER JL, McCARTY DJ, YU T: Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895-900.
13. ALTMAN R, ASCH E, BLOCH D et al.: Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. Arthritis Rheum 1986; 29: 1039-49.
14. CARMONA L, HERNANDEZ-GARCIA CH, VADILLO C et al.: Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 2003; 30: 1436-9.
15. CUSH JJ, YAZICI H: Laboratory monitoring of biologic therapies. Clin Exp Rheumatol 2005; 23 (Suppl. 39): S90-2.
16. BIEBER J, KAVANAUGH A: Tuberculosis and opportunistic infections: relevance to biologic agents. Clin Exp Rheumatol 2004; 22 (Suppl. 35): S126-33.
17. DAWSON JK, FEWINS HE, DESMOND J, LYNCH MP, GRAHAM DR: Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests. Thorax 2001; 56: 622-7.
18. SALAFFI F, CAROTTI M, BALDELLI S et al.: Subclinical interstitial lung involvement in rheumatic diseases. Correlation of high resolution computerized tomography and functional and cytology findings. Radiol Med (Torino) 1999; 97: 33-41.
19. SARACOGLU M, NACIR B, INCEL NA, GENÇ H, ERDEM HR: Relationship between high resolution computed tomography findings and the Stoke index in patients with rheumatoid arthritis. Clin Rheumatol 2005; 24: 14-7.
20. BIEDERER J, SCHNABEL A, MUHLE C, GROSS WL, HELLER M, REUTER M: Correlation between HRCT findings, pulmonary function tests and bronchoalveolar lavage cytology in interstitial lung disease associated with rheumatoid arthritis. Eur Radiol 2004: 14; 272-80.
21. de LEON DP, ACEVEDO-VASQUEZ E, SANCHEZ-TORRES A et al.: Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalance of tuberculosis. Ann Rheum Dis 2005; 64: 1360-1.
22. WOLFE F, MICHAUD K, ANDERSON J, URBANSKY K: Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum 2004; 50: 372-9.
23. SCHATZ P, PATTERSON R, KLONER R, FALK J: The prevalance of tuberculosis and positive tuberculin skin test in a steroid-treated asthmatic population. Ann Intern Med 1976; 84: 261-5.